Pediatric osteogenic sarcoma

Current Opinion in Pediatrics

Volumn 22, Issue 1, 2010, Pages 61-66

  Kim, Han Jo ^a   Chalmers, Peter N ^b   Morris, Carol D ^c  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bone neoplasms; Osteosarcoma; Pediatric

Indexed keywords

CISPLATIN; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; MURAMYL TRIPEPTIDE; PEMETREXED; TOPOTECAN;

CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; HUMAN; LIMB SALVAGE; LUNG METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SURVIVAL TIME;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; DIAGNOSTIC IMAGING; HUMANS; LIMB SALVAGE; LUNG NEOPLASMS; NEOPLASM STAGING; OSTEOSARCOMA; PROSTHESES AND IMPLANTS;

EID: 75749099777     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328334581f     Document Type: Review

References (48)

1. Wang L. Biology of osteogenic sarcoma. Cancer J 2005; 11:294-305.
2. Hayden J, Hoang BH. Osteosarcoma: basic science and clinical implications. Orthop Clin North Am 2006; 37:1-7.
3. Longhi A, Errani C, De Paolis M, et al. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 2006; 32:423-436.
4. Dahlin D, Coventry MB. Osteogenic sarcoma. A study of six hundred cases. J Bone Joint Surg Am 1967; 49:101-110.
5. Bielack S, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002; 20:776-790.
6. Meyers P, Schwartz CL, Krailo M, et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicine, and high-dose methotrexate. J Clin Oncol 2005; 23:2004-2011.
7. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol 2000; 18:4016-4027.
8. Varan A, Yazici N, Aksoy C, et al. Treatment results of pediatric osteosarcoma: twenty-year experience. J Pediatr Orthop 2007; 27:241-246.
9. Morrissy R, Weinstein SL. Lovell and Winter's pediatric orthopaedics. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2006.
10. Horner M, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2009.
11. Widhe B, Widhe T. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am 2000; 82:667-674.
12. Scully S, Ghert MA, Zurakowski D, et al. Pathologic fracture in osteosarcoma. J Bone Joint Surg Am 2002; 84A:49-57.
13. Kuhelj D, Jereb B. Pediatric osteosarcoma: a 35-year experience in Slovenia. Pediatr Hematol Oncol 2005; 22:335-343.
14. Ferrari S, Bertoni F, Mercuri M, et al. Predictive factors of disease-free survival for nonmetastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol 2001; 12:1145-1150.
15. Grimer R, Carter SR, Tillman RM, Abudu A. Early symptoms and diagnosis of bone tumors. J Bone Joint Surg Am 2001; 83:1107-1108.
16. Lee JA, Kim MS, Kim DH, et al. Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma. Pediatr Blood Cancer 2008; 50:195-200.
17. Franzius C, Daldrup-Link HE, Sciuk J, et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 2001; 12:479-486.
18. Kneisl JS, Patt JC, Johnson JC, Zuger JH. Is PET useful in detecting occult nonpulmonary metastases in pediatric bone sarcomas? Clin Orthop Relat Res 2006; 450:101-104.
19. Bruland OS, Hoifodt H, Saeter G, et al. Hematogenous micrometastases in osteosarcoma patients. Clin Cancer Res 2005; 11:4666-4673.
20. Mankin HJ, Hornicek FJ, Rosenberg AE, et al. Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res 2004; 429:286-291.
21. Kilpatrick SE, Cappellari JO, Bos GD, et al. Is fine-needle aspiration biopsy a practical alternative to open biopsy for the primary diagnosis of sarcoma? Experience with 140 patients. Am J Clin Pathol 2001; 115:59-68.
22. Klein M, Siegal GP. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol 2006; 125:555-581.
23. van den Berg H, Slaar A, Kroon HM, et al. Results of diagnostic review in pediatric bone tumors and tumorlike lesions. J Pediatr Orthop 2008; 28:561-564.
24. Rose P, Dickey ID, Wenger DE, et al. Periosteal osteosarcoma: long-term outcome and risk of late recurrence. Clin Orthop Relat Res 2006; 453:314-317.
25. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980:106-120.
26. Messerschmitt PJ, Garcia RM, Abdul-Karim FW, et al. Osteosarcoma. J Am Acad Orthop Surg 2009; 17:515-527.
27. Goorin AM, Schwartzentruber DJ, Devidas M, et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 2003; 21:1574-1580.
28. Wilkins RM, Cullen JW, Camozzi AB, et al. Improved survival in primary nonmetastatic pediatric osteosarcoma of the extremity. Clin Orthop Relat Res 2005; 438:128-136.
29. Mackat G, Tkachev SI, Solovyev YN, et al. Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities. Mayo Clin Proc 2003; 78:147-155.
30. Ferrari S, Smeland S, Mercuri M, et al. Neoadjuvant chemotherapy with highdose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study of the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005; 23:8845-8852.
31. Thomas DG, Giordano TJ, Sanders D, et al. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma. Clin Cancer Res 2002; 8:788-793.
32. Leu KM, Ostruszka LJ, Shewach D, et al. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma. J Clin Oncol 2004; 22:1706-1712.
33. Saylors RL 3rd, Stine KC, Sullivan J, et al. Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study. J Clin Oncol 2001; 19:3463-3469. (Pubitemid 32730082)
34. Kindler HL. The pemetrexed/gemcitabine combination in pancreatic cancer. Cancer 2002; 95 (4 Suppl):928-932.
35. Kim M, Lee SY, Cho WH, et al. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients. Ann Surg Oncol 2008; 15:906-914.
36. Jaffe N, Carrasco H, Raymond K, et al. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? Cancer 2002; 95:2202-2210.
37. Neel MD, Heck R, Britton L, et al. Use of a smooth press-fit stem preserves physeal growth after tumor resection. Clin Orthop Relat Res 2004:125-128.
38. Kager I, Zoubek A, Potschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003; 21:2011-2018.
39. Virkus WW, Marshall D, Enneking WF, Scarborough MT. The effect of contaminated surgical margins revisited. Clin Orthop Relat Res 2002:89-94.
40. Bacci G, Ferrari S, Lari S, et al. Osteosarcoma of the limb: amputation or limb salvage in patients treated with neoadjuvant chemotherapy. J Bone Joint Surg Br 2002; 84:88-92.
41. Nagarajan R, Clohisy DR, Neglia JP, et al. Function and quality-of-life of survivors of pelvic and lower extremity osteosarcoma and Ewing's sarcoma: the Childhood Cancer Survivor study. Br J Cancer 2004; 91:1858-1865.
42. Grimer R. Surgical options for children with osteosarcoma. Lancet Oncol 2005; 6:85-92.
43. Neel MD, Wilkins RM, Rao BN, Kelly CM. Early multicenter experience with a noninvasive expandable prosthesis. Clin Orthop Relat Res 2003:72-81.
44. Reach JS Jr, Dickey ID, Zobitz ME, et al. Direct tendon attachment and healing to porous tantalum: an experimental animal study. J Bone Joint Surg Am 2007; 89:1000-1009.
45. Jeys L, Kulkarni A, Grimer RJ, et al. Endoprosthetic reconstruction for the treatment of musculoskeletal tumors of the appendicular skeleton and pelvis. J Bone Joint Surg Am 2008; 90:1265-1271.
46. Morgan H, Cizik AM, Leopold SS, et al. Survival of tumor megaendoprostheses replacements about the knee. Clin Orthop Relat Res 2006; 450:39-45.
47. Jeys L, Grimer RJ, Carter SR, Tillman RM. Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg Am 2005; 87:842-849.
48. Muscolo DL, Ayerza MA, Aponte-Tinao L, Farfalli G. Allograft reconstruction after sarcoma resection in children younger than 10 years old. Clin Orthop Relat Res 2008; 466:1856-1862.